Summarized by Masters of Longevity from Lifespan.io.
A September roundup surveys recent geroscience and longevity developments, covering interventions, biomarkers, microbiome findings, and translational frameworks.
Key Takeaways
- Late-life semaglutide increased median lifespan in female mice by over 12% and improved multiple health markers.
- Six aging clocks detected younger blood protein profiles in patients taking the experimental lung fibrosis drug rentosertib.
- A pilot rapamycin trial in healthy middle-aged APOE4 carriers improved cerebral blood flow and altered metabolic and inflammatory profiles.
